GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

VistaGen Therapeutics Inc stock upgraded from Sell Candidate to Hold/Accumulate after Monday trading session.
(Updated on Apr 22, 2024)

Hold candidate since Apr 22, 2024 PDF

The VistaGen Therapeutics Inc stock price gained 0.420% on the last trading day (Monday, 22nd Apr 2024), rising from $4.76 to $4.78. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.84% from a day low at $4.74 to a day high of $4.87. The price has risen in 6 of the last 10 days but is still down by -7.54% for this period. Volume fell on the last day by -14 thousand shares and in total, 138 thousand shares were bought and sold for approximately $661.28 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.25% during the next 3 months and, with a 90% probability hold a price between $3.78 and $5.25 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTGN Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -11.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The VistaGen Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.74 and $4.64. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.49 and $4.24. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $4.49. If this is broken, then the next support from accumulated volume will be at $4.24 and $4.17.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.134 between high and low, or 2.84%. For the last week the stock has had daily average volatility of 4.50%.

Our recommended stop-loss: $4.53 (-5.20%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (VTGN) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect VistaGen Therapeutics Inc to open at $4.79, and during the day (based on 14 day Average True Range), to move between $4.48 and $5.08, which gives a possible trading interval of +/-$0.298 (+/-6.24%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 12.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.85 (1.46%) than the support at $4.49 (6.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is VistaGen Therapeutics Inc stock A Buy?

VistaGen Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.050 Hold/Accumulate Upgraded

Predicted Opening Price for VistaGen Therapeutics Inc of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$4.79 ( 0.310%) $4.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.93 3.12 %
R2 4.88 2.05 %
R1 4.85 1.38 %
Current price: 4.78
Support S1 4.74 -0.764 %
S2 4.71 -1.43 %
S3 4.66 -2.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.40 12.97 %
R2 5.28 10.46 %
R1 4.85 1.46 %
Current price 4.78
Support S1 4.49 -6.07%
S2 4.24 -11.40%
S3 4.17 -12.76%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the Apr 22, 2024, the price of an VistaGen Therapeutics Inc (VTGN) share was $4.78.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $24.71 and the 52-week low is $1.62.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the Apr 22, 2024, the market capitalization of VistaGen Therapeutics Inc is 128.64M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is Jun 26, 2024.
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT